Baxalta Inc. and Baxalta GmbH (Baxalta) appealed a district court decision that the claims of U.S. Patent No. 7,033,590 were invalid for lack of enablement.
On January 30, 2023, the U.S. Court of Appeals for the Third Circuit (the "Court") issued an opinion in In re LTL Management, LLC, No. 22-2003, 2023 WL 1098189, at 1 (3d Cir. Jan. 30, 2023) ("LTL Management").
In the United States Court of Appeals for the Eleventh Circuit's ("the Court") recently issued decision In re Bozeman, 2023 U.S. App. LEXIS 545 (11th Cir., Jan. 10, 2023, No. 21-10987).
As post grant review allows for on sale bar assertions, and thus experimental use defenses, we wanted to highlight a recent case addressing these issues. Sunoco sued.
Seventh Circuit recently issued a decision highlighting importance of conducting objectively reasonable or good faith peer review action in situations involving termination of physician’s clinical privileges and protections provided under Health Care Quality and Improvement Act HCQIA.